Cytogenetic studies in a 40-year-old woman with follicular lymphoma demonstrate a t(14;18) chromosomal translocation involving the bcl-2 gene. Constitutive expression of the protein encoded by the bcl-2 gene inhibits which of the following processes in this patient’s transformed lymphocytes?

**Core Concept**
The bcl-2 gene is a key regulator of apoptosis, or programmed cell death, in normal cells. However, in cancer, including follicular lymphoma, the bcl-2 gene is often constitutively expressed, leading to an inhibition of apoptosis and promoting uncontrolled cell growth.

**Why the Correct Answer is Right**
In follicular lymphoma, the t(14;18) chromosomal translocation leads to the overexpression of the bcl-2 protein. This protein acts as an anti-apoptotic factor by inhibiting the activation of caspases, a family of cysteine proteases that are essential for the execution phase of cell death. By blocking the activation of caspases, the bcl-2 protein prevents the degradation of cellular components and the eventual cell death that would normally occur in response to DNA damage or other forms of cellular stress.

**Why Each Wrong Option is Incorrect**
* **Option A:** Apoptosis is the correct answer, but the other options are not directly related to the inhibition of bcl-2.
* **Option B:** DNA replication is not directly related to the inhibition of bcl-2, although it is an important process in cell growth and division.
* **Option C:** Protein synthesis is not directly related to the inhibition of bcl-2, although it is an important process in cell growth and division.

**Clinical Pearl / High-Yield Fact**
The bcl-2 gene is often used as a diagnostic marker for follicular lymphoma, and the t(14;18) chromosomal translocation is a key prognostic factor for this disease. Understanding the role of bcl-2 in apoptosis is essential for developing targeted therapies for cancer treatment.

**Correct Answer:** A. Apoptosis

✓ Correct Answer: A. Apoptosis